The Valley Desk

NCT05239728 · Interventional trial

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Overall registry status Active not recruiting

Phase 3

Conditions Carcinoma, Renal Cell

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov